Blis Technology stock jumped 50% on news of wider rollout through Sinopharm

Blis Technologies chief executive Dr Barry Richardson
Blis Technologies 12-month price history (NZX.com)

Blis Technologies [NZX: BLT] shares soared 50 percent after the biotech company said its Chinese partner planned to roll out a much wider market test of its probiotic products for mouth and throat health than it had initially indicated.

The shares jumped 1 cent to 3 cents on the NZX, the highest since November last year, valuing the company at $33 million.

The company said that following a test market trial through Sinopharm, the largest oral health and pharmaceutical company in China, its Chinese partner now planned to release Blis products in 600 pharmacies across the country, from 30 currently.

"This is still an early phase of commercialisation ," chief executive Barry Richardson told BusinessDesk. "If you think about the size of China, then it's not a large number (of pharmacies) in relation to that. Suffice to say, they are pretty positive about the development to go to the next level."

The Dunedin-based biotech company has been long in development, having first listed on the NZX in July 2001.

(BusinessDesk)


Got a question about this story? Leave it in Comments & Questions below.

This article is tagged with the following keywords. Find out more about MyNBR Tags

NZ Market Snapshot

Forex

Sym Price Change
USD 0.6577 -0.0023 -0.35%
AUD 0.9028 -0.0023 -0.25%
EUR 0.6017 -0.0017 -0.28%
GBP 0.4218 -0.0012 -0.28%
HKD 5.0990 -0.0171 -0.33%
JPY 81.5680 -0.3310 -0.40%

Commods

Commodity Price Change Time
Gold Index 1088.6 -4.010 2015-07-30T00:
Oil Brent 53.3 -0.070 2015-07-30T00:
Oil Nymex 48.5 -0.250 2015-07-30T00:
Silver Index 14.7 -0.040 2015-07-30T00:

Indices

Symbol Open High Last %
NZX 50 5891.9 5910.6 5891.9 0.23%
NASDAQ 5100.3 5135.6 5111.7 0.33%
DAX 11305.5 11313.3 11211.9 0.40%
DJI 17743.2 17761.2 17751.4 -0.03%
FTSE 6631.0 6697.4 6631.0 0.57%
HKSE 24822.4 24872.7 24619.5 -0.49%
NI225 20506.5 20537.5 20522.8 0.03%